PT82635B - Processo para a preparacao de uma composicao de libertacao controlada de uma droga macromolecular e respectivo metodo de tratamento com a referida composicao - Google Patents

Processo para a preparacao de uma composicao de libertacao controlada de uma droga macromolecular e respectivo metodo de tratamento com a referida composicao

Info

Publication number
PT82635B
PT82635B PT82635A PT8263586A PT82635B PT 82635 B PT82635 B PT 82635B PT 82635 A PT82635 A PT 82635A PT 8263586 A PT8263586 A PT 8263586A PT 82635 B PT82635 B PT 82635B
Authority
PT
Portugal
Prior art keywords
composition
preparation
treatment
macromolecular drug
controlled liberation
Prior art date
Application number
PT82635A
Other languages
English (en)
Other versions
PT82635A (en
Inventor
Kallidaikuric Sivaramakrishnan
Mohamad D Shalati
Original Assignee
Int Minerals & Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Minerals & Chem Corp filed Critical Int Minerals & Chem Corp
Publication of PT82635A publication Critical patent/PT82635A/pt
Publication of PT82635B publication Critical patent/PT82635B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/07—Microporous membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Fluid-Pressure Circuits (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Graft Or Block Polymers (AREA)
PT82635A 1985-05-24 1986-05-23 Processo para a preparacao de uma composicao de libertacao controlada de uma droga macromolecular e respectivo metodo de tratamento com a referida composicao PT82635B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/737,629 US4666704A (en) 1985-05-24 1985-05-24 Controlled release delivery system for macromolecules

Publications (2)

Publication Number Publication Date
PT82635A PT82635A (en) 1986-06-01
PT82635B true PT82635B (pt) 1988-07-29

Family

ID=24964638

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82635A PT82635B (pt) 1985-05-24 1986-05-23 Processo para a preparacao de uma composicao de libertacao controlada de uma droga macromolecular e respectivo metodo de tratamento com a referida composicao

Country Status (15)

Country Link
US (1) US4666704A (pt)
EP (1) EP0204476B1 (pt)
JP (1) JP2755298B2 (pt)
KR (1) KR940000001B1 (pt)
CN (1) CN1020851C (pt)
AT (1) ATE78155T1 (pt)
AU (1) AU590565B2 (pt)
CA (1) CA1277237C (pt)
DE (1) DE3685992T2 (pt)
DK (1) DK171758B1 (pt)
ES (1) ES8707666A1 (pt)
IE (1) IE59684B1 (pt)
IL (1) IL78895A (pt)
PT (1) PT82635B (pt)
ZA (1) ZA863867B (pt)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
IE63321B1 (en) * 1986-02-03 1995-04-05 Elan Corp Plc Drug delivery system
AU601443B2 (en) * 1986-05-16 1990-09-13 Monash Medical Centre Biocompatible implants
US5342622A (en) * 1986-05-16 1994-08-30 The State Of Victoria Subdermal biocompatible implants
WO1987006828A1 (en) * 1986-05-16 1987-11-19 The State Of Victoria Biocompatible implants
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5141748A (en) * 1989-02-17 1992-08-25 Hoffmann-La Roche, Inc. Implant drug delivery device
ES2042292T3 (es) * 1989-03-17 1993-12-01 Pitman-Moore, Inc. Dispositivo de administracion de proteinas macromoleculares por liberacion controlada.
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (pt) * 1989-07-28 1992-01-15 Debiopharm Sa
GB8928250D0 (en) * 1989-12-14 1990-02-21 Erba Carlo Spa Use of supercritical fluids to obtain porous sponges of biodegradable polymers
CA2050067C (en) * 1990-08-30 2000-05-30 Yasushi Morita Controlled drug release composition
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
GB2295316B (en) * 1994-11-25 1997-09-10 William Leslie Porter Bolus for supplying biologically beneficial substances to ruminant animals
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
US7550005B2 (en) * 1995-06-07 2009-06-23 Cook Incorporated Coated implantable medical device
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US7896914B2 (en) * 1995-06-07 2011-03-01 Cook Incorporated Coated implantable medical device
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
US20060025726A1 (en) * 1996-06-04 2006-02-02 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with pharmacologically active layer
US20060030826A1 (en) * 1996-06-04 2006-02-09 Vance Products Incorporated,d/b/a Cook Urological Incorporated Implantable medical device with anti-neoplastic drug
US6022554A (en) * 1997-12-15 2000-02-08 American Home Products Corporation Polymeric microporous film coated subcutaneous implant
KR20000022894A (ko) * 1998-09-05 2000-04-25 이승진 생분해성 고분자 미립자형 제제 및 그 제조방법
US6730349B2 (en) 1999-04-19 2004-05-04 Scimed Life Systems, Inc. Mechanical and acoustical suspension coating of medical implants
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
AU2000255261A1 (en) * 2000-05-26 2001-12-11 C.T.P. Cable Technology Procurement Ag Means for maintenance and/or correction of glucose concentration in blood
US7803149B2 (en) 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
WO2003000156A1 (en) * 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US8750983B2 (en) 2004-09-20 2014-06-10 P Tech, Llc Therapeutic system
PL1824460T3 (pl) * 2004-11-10 2015-09-30 Tolmar Therapeutics Inc Stabilizowany polimerowy układ dostarczania
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
US20070141106A1 (en) * 2005-10-19 2007-06-21 Bonutti Peter M Drug eluting implant
US20070106271A1 (en) * 2005-11-09 2007-05-10 Searete Llc, A Limited Liability Corporation Remote control of substance delivery system
US8475829B2 (en) * 2006-04-06 2013-07-02 Nupathe Inc. Implants for the treatment of dopamine associated states
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
US20210007973A1 (en) * 2016-10-05 2021-01-14 Titan Pharmaceuticals, Inc. Implantable devices for drug delivery with reduced burst release
AU2018345844B2 (en) 2017-10-06 2024-03-07 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
US12364792B2 (en) 2018-01-08 2025-07-22 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
AU2019270779B2 (en) 2018-05-12 2024-08-01 Foundry Therapeutics, Inc. Implantable depots for the controlled release of therapeutic agents
KR20210013088A (ko) * 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
KR20210013089A (ko) * 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
WO2020047013A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics, Inc. Polymer implants
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
AR206692A1 (es) * 1972-12-27 1976-08-13 Alza Corp Agente dispensador de liberacion sostenida de substancias activas
US4351337A (en) * 1973-05-17 1982-09-28 Arthur D. Little, Inc. Biodegradable, implantable drug delivery device, and process for preparing and using the same
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
US4391797A (en) * 1977-01-05 1983-07-05 The Children's Hospital Medical Center Systems for the controlled release of macromolecules
US4127127A (en) * 1977-05-23 1978-11-28 Alza Corporation Therapeutic systems made from certain segmented copolyesters
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers
IN152178B (pt) * 1978-05-08 1983-11-05 Pfizer
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
JPS593962B2 (ja) * 1980-06-24 1984-01-27 日東電工株式会社 徐放性酵素製剤
JPS593963B2 (ja) * 1980-06-24 1984-01-27 日東電工株式会社 徐放性酵素製剤
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
US4377568A (en) * 1981-08-12 1983-03-22 Merck Sharp & Dohme (I.A.) Corp. Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same

Also Published As

Publication number Publication date
DE3685992D1 (de) 1992-08-20
DK243886A (da) 1986-11-25
DE3685992T2 (de) 1992-12-24
JP2755298B2 (ja) 1998-05-20
JPS61277629A (ja) 1986-12-08
AU590565B2 (en) 1989-11-09
US4666704A (en) 1987-05-19
AU5767286A (en) 1986-11-27
EP0204476A1 (en) 1986-12-10
PT82635A (en) 1986-06-01
ATE78155T1 (de) 1992-08-15
CN1020851C (zh) 1993-05-26
IL78895A0 (en) 1986-09-30
EP0204476B1 (en) 1992-07-15
KR940000001B1 (ko) 1994-01-05
CA1277237C (en) 1990-12-04
ES555277A0 (es) 1987-08-16
DK243886D0 (da) 1986-05-23
IE861370L (en) 1986-11-24
ES8707666A1 (es) 1987-08-16
KR860008776A (ko) 1986-12-18
IL78895A (en) 1991-01-31
ZA863867B (en) 1987-01-28
DK171758B1 (da) 1997-05-12
CN86104226A (zh) 1987-02-25
IE59684B1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
PT82635B (pt) Processo para a preparacao de uma composicao de libertacao controlada de uma droga macromolecular e respectivo metodo de tratamento com a referida composicao
BR8804074A (pt) Polimero com unidades recorrentes,composicao estabilizante,processo para a preparacao de um estabilizante,e,composicao polimerica
DK153164C (da) Biokompatible, antithrombotiske organiske polymere materialer, som er velegnede til rekonstruktionskirurgi samt anvendelse heraf til fremstilling af et implantat
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
EP0138740A3 (en) Synthetic resin wound dressing and method of manufacturing
BR0200311A (pt) Processo para preparar composição para revestimento, e, composição aquosa para revestimento
CA2290743A1 (en) Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
DK0932391T3 (da) Fusogen liposomsammensætning og fremgangsmåde
NO931809L (no) Hemofilter
AU585377B2 (en) Controlled release pharmaceutical composition
ATE384502T1 (de) Verfahren zur herstellung einer medizinischen einrichtung mit poröser oberfläche zur kontrollierten wirkstofffreigabe
BR9809064A (pt) Polìmeros biodegradáveis de poliéster de tereftalato-polifosfato, composições, artigos e métodos para fazer e usar os mesmos
ATE277647T1 (de) Antiadhäsionsschicht aus hyaluronsäure
ES2058313T3 (es) Procedimiento para prevenir la formacion de incrustaciones de polimero.
DE59805591D1 (de) Verfahren zur Herstellung von Mikrostrukturkörpern
NO177826C (no) Belegningsmateriale omfattende en eroderbar polymer med hydrolyserbare sulfonatestergrupper, samt sulfonatestergruppeholdig vann-eroderbar polymer
ES2029853T5 (es) Base de unguento y unguento.
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
DE68916399D1 (de) Lösungsmittelfreier festes Polymerelektrolyt und Verfahren zu seiner Herstellung.
ATE56736T1 (de) Waessrige ueberzugsmittelzusammensetzungen mit hohen feststoffgehalten.
ES2079598T3 (es) Procedimiento para el revestimiento de principios activos con un polimero sensible al ph.
BR8307277A (pt) Composicao aquosa para revestimento e processos para preparacao da mesma
BR8600385A (pt) Processo para preparacao de polimero ou copolimero aperfeicoado modificado,de tereftalato do polietileno
BR8901477A (pt) Composicao polimerica,processo para aperfeicoamento da estabilidade de uma composicao de polimero olefina e poliorgano siloxano
ES2016628B3 (es) Composicion polimera alfa-olefinica ramificada y procedimiento para su produccion.

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010731